Lightnews — Scholar-powered news

The Lancet Gastroenterology & Hepatology

@lancetgastrohep.bsky.social

950 followers 75 following 150 posts

The Lancet Gastroenterology & Hepatology is the world-leading #gastroenterology and #hepatology research journal. IF=38.6. 🌐 thelancet.com/journals/langas/home

Posts Media Videos Starter Packs

Pinned

The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · Jul 3

We are the world-leading journal dedicated to gastroenterology & hepatology research and review.

While a partial measurement of our impact, we are pleased to share our 2024 Impact Factor is 38·6 and our CiteScore is 51·1.

hubs.li/Q03v92mL0

#GastroSky #MedSky #LiverSky

Publish with The Lancet Group

hubs.li

1 1

The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · 1d

New research - Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis

www.thelancet.com/journals/lan...

#GastroSky #MedSky @alexanderford25.bsky.social @romegastropsych.bsky.social

Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis

Several behavioural therapies are efficacious for global symptoms in IBS, although the most evidence exists for those classed as brain–gut behaviour therapies. However, certainty in the evidence for a...

www.thelancet.com

3 2

The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · 3d

Our latest issue is out now at www.thelancet.com/gastrohep!

Content includes #obesity, #MASLD, #FMT for #Cdiff #viralhepatitis, #cirrhosis, #DGBI & more!

#GastroSky #LiverSky #MedSky

4 3

The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · 6d

The full ENDURO report has just been published at @LancetGastroHep - www.thelancet.com/journals/lan...

#GastroSky #MedSky #UEGWeek

2 1

The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · 6d

Palliative treatment with endoscopic gastroenterostomy was superior to surgical gastroenterostomy for time to resumption of solid oral intake and was non-inferior for the rate of persistent or recurrent obstructive symptoms requiring re-intervention

#GastroSky #MedSky #UEGWeek

1 2 2

The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · 6d

Opening plenary time at #UEGWeek!

The first research of the session is presented by Yorick van de Pavert, with the ENDURO trial of endoscopic versus surgical gastroenterostomy for palliation of malignant gastric outlet obstruction

#GastroSky #MedSky

1 2 2

The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · 6d

Let’s go…

#UEGWeek #GastroSky #MedSky

2 2

Reposted by The Lancet Gastroenterology & Hepatology

The Lancet Oncology @thelancetoncol.bsky.social · 11d

🚨Our Oct issue is live -
thelancet.com/issue/S1470-...

📈Articles: on #RCC, #SCLC, #NSCLC, #BladderCancer, #Myeloma, #PancreaticCancer,
#EndometrialCancer, and #ThyroidCancer

📝Reviews: EU–CAYAS–NET recommendations for health-care transitions in young people beyond
childhood cancer

Reposted by The Lancet Gastroenterology & Hepatology

The Lancet @thelancet.com · 9d

🔔 Introducing The Lancet Regional Health – Africa, a new #goldopenaccess journal promoting the advancement of clinical practice and health policy in Africa.

Explore the new journal at hubs.li/Q03KzMp00 #MedSky

A special preview issue of The Lancet Regional Health – Africa. On the cover is a photograph of a doctor examining a Maasai baby. Copyright: Hugh Sitton/Getty Images

1 14 22

Reposted by The Lancet Gastroenterology & Hepatology

World Hepatitis Alliance @worldhepalliance.bsky.social · 10d

Hepatitis B Foundation & ICE-HBV are co-hosting a moderated panel discussion on the rationale for expanded & early treatment of hepatitis B.

It covers two recent co-authored papers published in @lancetgastrohep.bsky.social & our WPRO Board Member, Thomas Tu, is a panelist.

Register: bit.ly/46NSW0O

2 1

Reposted by The Lancet Gastroenterology & Hepatology

Rob Brierley @robbrierley.bsky.social · 10d

New research - Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a phase 3 study

www.thelancet.com/journals/lan...

#GastroSKy #MedSky #IBD @lancetgastrohep.bsky.social

Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicent...

Etrasimod was effective and well tolerated as an oral induction and maintenance treatment in patients with moderately to severely active ulcerative colitis in East Asia.

www.thelancet.com

1 1

Reposted by The Lancet Gastroenterology & Hepatology

Philippa Matthews @pippa-matt.bsky.social · 16d

Scientific, public health & lived experience rationale for expanding #hepatitis B treatment.
Webinar hosted by @ice-hbv.bsky.social & #HepatitisBFoundation.
Details in flyer 👇
#HBV #HepSky #LiverSky #MedSky 🧪💊🌍
@suwang88.bsky.social
@lancetgastrohep.bsky.social
www.hepb.org

Flyer for webinar on hepatitis B treatment, scheduled for Oct 23 205 4pm EDT.

2 7

Reposted by The Lancet Gastroenterology & Hepatology

Rob Brierley @robbrierley.bsky.social · 13d

I'll be at #UEGWeek in Berlin October 5-7! If you'd like to discuss your research or ideas for reviews or opinion pieces, or just catch up over a coffee, please drop me a line!

#gastroenterology #UEGWeek2025

2 1

Reposted by The Lancet Gastroenterology & Hepatology

Rob Brierley @robbrierley.bsky.social · 18d

New @lancetgastrohep.bsky.social

Non-inferiority of lyophilised faecal filtrate vs lyophilised donor stool was not established for the prevention of C difficile recurrence over 8 weeks

👉 Live 🦠 crucial in mediating clinical efficacy

www.thelancet.com/journals/lan...

#GISky #IDSky #MicroSky #FMT

2 4

Reposted by The Lancet Gastroenterology & Hepatology

Sebastian Schmidt @tsbschm.bsky.social · 18d

Fecal filtrate is less effective than donor stool (FMT) for the treatment of C. difficile recurrence. Now shown in a multicentre trial, out today in @lancetgastrohep.bsky.social .

Congratulations to Dina Kao @ualberta.bsky.social & team!

Gift link:

authors.elsevier.com/c/1lphg8nByr...

authors.elsevier.com

1 10 24

Reposted by The Lancet Gastroenterology & Hepatology

HepB Cant Wait @suwang88.bsky.social · 24d

The ACIP meeting is Sept 9/18-9/19 and the hepatitis B vaccine is at stake.
www.nytimes.com/2025/09/16/w...

@altcdc.altgov.info @worldhepalliance.bsky.social
@lancetgastrohep.bsky.social @altfda.altgov.info @aasldnews.bsky.social #IDsky #Liversky

The Hepatitis B Vaccine Is Under Threat. Here’s What to Know.

www.nytimes.com

5 15

The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · 29d

New research - Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review & meta-analysis

www.thelancet.com/journals/lan...

#LiverSky #MedSky

Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systemati...

MetALD might be associated with a higher risk of liver-related events, hepatocellular carcinoma, and extrahepatic cancers than MASLD, whereas all-cause mortality, extrahepatic cancer-related mortality...

www.thelancet.com

1 3

Reposted by The Lancet Gastroenterology & Hepatology

The Lancet Oncology @thelancetoncol.bsky.social · 29d

🚨Our Sept issue is live - 25 years! thelancet.com/journals/lan...

📊Articles #renalcellcarcinoma, #prostatecancer, #meningioma, #thymiccarcinoma, & #colorectalcancer

Reviews: 📰 ESTRO and ASTRO plus endorsed guidelines on vol delineation & 📰 Common Sense Oncology and EORTC on reporting QoL data

3 6

Reposted by The Lancet Gastroenterology & Hepatology

The Lancet @thelancet.com · 29d

Shigellosis is the most common cause of invasive bloody diarrhoea in children younger than 5 years.

The prevention of infection with vaccination & sanitation strategies remains a crucial step in reducing worldwide morbidity & mortality.

Find out more ▶️ tinyurl.com/ard69t83

Figure showing the immunopathogenesis of Shigella infection in the colon. MAMPs=microbe-associated molecular patterns. DAMPs=damage-associated molecular patterns. NK=natural killer. Adapted from Schnupf and Sansonetti. Copyright: 2025 Elsevier Ltd. All rights are reserved.

1 8 8

The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · Sep 11

New research - Phosphatidylethanol and self-reported alcohol intake to subclassify in individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study

www.thelancet.com/journals/lan...

#LiverSky #MedSky @aleksanderkrag.bsky.social @israelsenm.bsky.social

1 5

Reposted by The Lancet Gastroenterology & Hepatology

Mads Israelsen @israelsenm.bsky.social · Sep 11

How should we use PEth in SLD care? 🩸🍺

Our study in @lancetgastrohep.bsky.social (n≈3,000) shows:
🔍 39% of MASLD → MetALD/ALD with PEth
⨻ Triangulating self-report + AUDIT-C + PEth = better classification
⚖️ But 40% get no added value → use selectively

www.sciencedirect.com/science/arti...

Phosphatidylethanol and self-reported alcohol intake to subclassify in individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study

Phosphatidylethanol is a direct biomarker of alcohol consumption within the past 1–4 weeks, making it a potential tool in the subclassification of pat…

www.sciencedirect.com

1 4

Reposted by The Lancet Gastroenterology & Hepatology

The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · Sep 9

Our October Issue is now online, featuring prediabetes remission, obesity, type 1 diabetes, biased GLP-1 receptor agonists, type 2 diabetes, prolactin-secreting adenomas, malnutrition-related diabetes, food system, NCDs & much more www.thelancet.com/journals/lan...

#MedSky #EndoSky #OncSky

4 1

Reposted by The Lancet Gastroenterology & Hepatology

The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · Sep 6

Although very infrequent, cases of #hypothalamic #obesity are a challenging, often intractable medical condition, that can also help to elucidate mechanisms of obesity and eventually identify therapeutic targets www.thelancet.com/journals/lan...
#hyperphagia

#MedSky #EndoSky

Hypothalamic obesity: from basic mechanisms to clinical perspectives

Despite the diverse nature of obesity, there is compelling genetic, clinical, and experimental evidence that endorses the important contribution of brain circuits to this condition. The hypothalamus c...

www.thelancet.com

1 3 6

Reposted by The Lancet Gastroenterology & Hepatology

The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · Sep 6

People with #MASLD can progress to cirrhosis and hepatocellular carcinoma and are at increased risk of developing type 2 #diabetes, #cardiovascular disease, chronic #kidney disease, and extrahepatic #cancers www.thelancet.com/journals/lan...
#T2D #CVD #CKD
#OpenAccess

#MedSky #EndoSky #LiverSky

3 3

Reposted by The Lancet Gastroenterology & Hepatology

The Lancet Oncology @thelancetoncol.bsky.social · Sep 8

@thelancetoncol.bsky.social is pleased to announce we are partnering with @estroradiotherapy.bsky.social and Radiotherapy and Oncology for a second year at next year’s Congress in Stockholm. Please submit your abstracts!

www.estro.org/Congresses/E...

ESTRO 2026

www.estro.org

2 1

Reposted by The Lancet Gastroenterology & Hepatology

The Lancet Microbe @lancetmicrobe.bsky.social · Sep 9

Our September issue is now online:

www.thelancet.com/journals/lan...

Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #SARS-CoV-2 #HIV #Pneumocystis #tuberculosis #TB #gonorrhoea #Citrobacter #AMR #Salmonella

#IDSky #ClinMicro #OA

Cover of The Lancet Microbe's September issue with a "Light micrograph of a lung sample from an AIDS patient showing cysts of Pneumocystis [jirovecii]".

2 11 9